| Tag | Content |
|---|
EnhancerAtlas ID | HS091-11345 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr12:132414680-132416710 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr12:132415922-132415937 | TGAACTCCTGACCTC | - | 6.22 | | Nr5a2 | MA0505.1 | chr12:132415914-132415929 | GCTGGCCTTGAACTC | - | 8.25 | | RARA | MA0729.1 | chr12:132415919-132415937 | CCTTGAACTCCTGACCTC | - | 6.73 | | Stat6 | MA0520.1 | chr12:132415586-132415601 | CATTTCCACAGAAGT | + | 6.59 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 132415525 | 132415662 | | chr12 | 132415258 | 132415600 |
|
Enhancer Sequence | GTGTGGCCGC CCGGGAAGCG GCAGGTCCCG CGGGGTTTAG GTGCAGGTGC GGCCGCCGGG 60
GAAGCGGTGG GTCCGGCTGG GTTTAGGTGC AGGAGCGGTC GCCCAGGTAG CGGCGGGTCC 120
GGCAGGATTT AGGTGCAGGC CCAAGCAGCT TTCACTGCTC CTGCTGCACG CGAGCTCCTG 180
CTGCTTTCCA TCAGGCCCGG CCCTGCCGCT AACCGCTGTT ATCTGGGGCG GGGTTCACTT 240
GCTGGGTGCC TGAGTCCTCA TCTTTAGGAT GGGAGTGCTC ACAGCACCTG CTAAGTAGAG 300
TGTGAAGATG AGCTAGGTGT ACTGACGCTC GGTGCTGAGA ACAGTGGACA GCTCGGGGCA 360
GCTCAGAAGA GCCTGCTGTC GTGAGCGTTA AGGGGACAGA GAGCTAAGTA TTAAAGTTGT 420
GAGGATTCTC TCCTCAGCCC ACTTCCTTTT CTGGAAGGTA GAGGGTCTGG GTACATTCAG 480
GTAGGTGTAT TTTTTTTTCT TTTTGAGGCG TGGTCTCCCT TTGTGGTCCA GGCTGGAATG 540
CAGTGGTGCA TCCACACTGC TCGCTGCAGC CTCCACCTCC TGGGCTCAAG AGATCCTCCC 600
ACCTCAGCCT CCCGAACATC GAGGGCTGTA AGTGTCCTTG ACCTCACGGC CTGAATAATT 660
TTTTTTATAA TTTGCAGGAA TGGTGTCTTG CTAAGTTTTT TATTATTTAT AGGAATGGGG 720
TCTCGCTGTG TTGCCCAGGC TGCTCTCCAA CTCCTGGGCT CAAGCGATCC TCCTGCCTCG 780
GCCTTCCTGT GTTGTGATTA CAGGCATGAG CCACTGCGAC TGGCCTCAGG TAGACATTCC 840
TTTTGTTCCT TTTTGTAGTT ACCACTGTGG CTTTGCGCAG TTCTGTGTTC TTTAAACATC 900
TTTAAACATT TCCACAGAAG TTCATGCAGT GCGTGCAGTG TCTGACTGAA ACAAAAGTTT 960
AAGAAAATAA TGCTTAACTT CGGCAGTTGT TATAACAGCT TTTATGGTGA AAGTTATAAG 1020
TAATAGATTG CTTTTTTTTT GGAGACAGAG TCTTGCTCTG TCGCCCAGGC TGGAGTGCAG 1080
TGGTGGGATT TTGGCTTACT GCAGCCTCCG CCTCCCGGGT TCCACCGATT CTTGTGCCTC 1140
AGCCTCCCGA GTAGCTGGGA CTACAGGCGC TCGCCACCAC GCCCATCTAG TTTTTGTATT 1200
TTTAGTAGAG ACGGGGTTTC ACCATGTTGG TCAGGCTGGC CTTGAACTCC TGACCTCAGA 1260
GTATCCTCCT GTCTCCGTCT CCCAAAGTGC TGGAATTACA GGGGTGAGCC ACAGAGCCCG 1320
GCCAACCACT GTGCACTGCA ACCTCTGCCT CCCAGATTCA AGCAATTCTC CTGCCTCAGC 1380
CTCCTGAGTC ACTGGGATTA AAAGCATACC TAATTATTTA TTTATTTATT TATTTTTGAG 1440
ACAGAGTTTT CCTCTGTCAC CTAGGCTGGA GTGCAGTGGT ACATTATCAG TTCACTGCAA 1500
CCTCCACTTC CCAGGTTCAA GCGATTCTCC TGCCTCAAGA GCCCGGCACC ACGCCCGGCT 1560
AATTTTTGTA TTTTTAGTAG AGACAGAGTT TCACCATGTT GGCCAGACTG GTCTCGAACT 1620
CCTGATCTCA AGTGATCCAC CCTCCTCGGC CTCCCAAAGT GCTGGGATTA CAGGTGTGAG 1680
CCACTGCACC TGGCCATAGA TTACTTTATA GTCAATGTTT TTTTTTTAAA GTATAGGTAG 1740
CACCCACGGC ACTGATTTTG TAACTGACAG ATTGTGGAAG TAGGTGTATG CACAGGTTCA 1800
ATCAAACCTG TGTTTTGATT CCATTCCACA CTACCCACCC CCTAGCATGG AGCAGCCCGG 1860
CCCCAGGGTG AGTGAGCAGA AAACAGTGTT TTCACATGAG CGTGGCAGCT CACACTTGTA 1920
ATCTCAGCAC TTCAGGAGGC CAGAGGAGTA AGCGGCCAGG AGTTCGAGAC CAGCCTGGGC 1980
AACATCATGG CGACCTCTGT CTGCAAAATA TAAAATCTGT TTTTGTCTCC 2030
|
